Retinal degeneration-nanophthalmos-glaucoma syndrome Advocacy Hub | UniteRare

At a Glance

Live from database

💊

1FDA treatments

💰

1Open funds

Regulatory Watchboard

1 event

Feb 2009

MembraneBlue: FDA approved

For use as an aid in ophthalmic surgery by staining the epiretinal membranes during ophthalmic surgical vitrectomy procedures, facilitating removal of the tissue

FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Patient Assistance Programs1

MembraneBlue

Dutch Ophthalmic Research Center International BV

OpenContact for details

View all support programs on disease page →

Approved Treatments

1 FDA-approved

MembraneBlue

(Trypan blue)Orphan drug

Dutch Ophthalmic Research Center International BV

MembraneBlue 0.15% - Mechanism of action section. MembraneBlue 0.15% selectively stains membranes in the human eye during posterior surgery, such as e...

Approved Feb 2009FDA label ↗

View full treatment details on disease page →